ÀÚ±â Ç÷´ç ÃøÁ¤ ±â±â ½ÃÀå : Á¦Ç° À¯Çüº°, ±â¼úº°, °Ë»ç ºÎÀ§º°, ȯÀÚ À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° : ¼¼°è »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2025-2032³â)
Self-monitoring Blood Glucose Devices Market, By Product Type, By Technology, By Testing Site, By Patient Type, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
»óǰÄÚµå : 1781990
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 284 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,544,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,502,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,900,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

ÀÚ±â Ç÷´ç ÃøÁ¤ ±â±â ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 197¾ï 5,201¸¸ ´Þ·¯¿¡ ´ÞÇϸç, 2025-2032³â¿¡ CAGR 11.53%·Î È®´ë

Ç÷´ç ÀÚ°¡ ÃøÁ¤ ±â±â ½ÃÀå - ½ÃÀå ¿ªÇÐ

´ç´¢º´ À¯º´·ü Áõ°¡¿Í ±â¼ú Çõ½ÅÀ¸·Î ÀÚ°¡Ç÷´çÃøÁ¤±â ¼ö¿ä Áõ°¡ Àü¸Á

´ç´¢º´ À¯º´·ü Áõ°¡¿Í ±Þ¼ÓÇÑ ±â¼ú Çõ½ÅÀÌ ¸Â¹°·Á ÀÚ°¡ Ç÷´ç ÃøÁ¤ ±â±â°¡ Àü ¼¼°è¿¡¼­ º¸±ÞµÇ°í ÀÖ½À´Ï´Ù. ±¹Á¦´ç´¢º´¿¬¸Í(International Diabetes Federation)Àº Àü ¼¼°è ¼ºÀÎ 10¸í Áß 1¸íÀÌ ´ç´¢º´À» ¾Î°í ÀÖ´Ù°í º¸°íÇϰí ÀÖÀ¸¸ç, È¿°úÀûÀÎ ÀÚ°¡ °ü¸® ÅøÀÇ ½Ã±ÞÇÑ Çʿ伺À» °­Á¶Çϰí ÀÖ½À´Ï´Ù. ºñħ½ÀÀû ¼¾¼­¿Í ¸ð¹ÙÀÏ ¾Û ÅëÇÕ µîÀÇ ¹ßÀüÀ¸·Î Ç÷´ç ¸ð´ÏÅ͸µÀÌ ´õ¿í Æí¸®Çϰí Á¤È®ÇØÁö°í ÀÖ½À´Ï´Ù. ¹Ì±¹ Áúº´¿¹¹æÅëÁ¦¼¾ÅÍ(CDC)´Â Á¤±âÀûÀÎ Ç÷´ç ¸ð´ÏÅ͸µÀÌ ÇÕº´ÁõÀ» Å©°Ô ÁÙÀÌ°í ´ç´¢º´ ȯÀÚÀÇ »îÀÇ ÁúÀ» Çâ»ó½Ãų ¼ö ÀÖ´Ù°í °­Á¶Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àεµ¿Í ºê¶óÁú°ú °°Àº ±¹°¡¿¡¼­´Â Á¤ºÎ ÀÇ·á ÇÁ·Î±×·¥ÀÌ º¸Á¶±Ý°ú ÀÎ½Ä °³¼± Ä·ÆäÀÎÀ» ÅëÇØ ÀÌ·¯ÇÑ ±â±â¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» ³ô¿© ¼ö¹é¸¸ ¸íÀÇ È¯ÀÚ°¡ º¸´Ù È¿°úÀûÀ¸·Î Áúº´À» °ü¸®Çϰí ÀÇ·á ½Ã½ºÅÛÀÇ ºÎ´ãÀ» ÁÙÀÌ´Â µ¥ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù.

ÀÚ°¡ Ç÷´ç ÃøÁ¤ ±â±â ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®

´ç»çÀÇ ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®°¡ °øÀ¯ÇÑ ºÐ¼®¿¡ µû¸£¸é ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2025-2032³â) µ¿¾È ¿¬Æò±Õ ¾à 11.53%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Á¦Ç° À¯Çüº°·Î´Â ÀÚ°¡Ç÷´çÃøÁ¤±â(SMBG)°¡ 2024³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

±â¼úº°·Î´Â 2024³â Àü±âÈ­ÇÐ ±â¼úÀÌ ÁÖ¿ä ±â¼úÀ̾ú½À´Ï´Ù.

°Ë»ç ºÎÀ§º°·Î´Â ¼Õ°¡¶ô ³¡ÀÌ 2024³â ÁÖ¿ä °Ë»ç ºÎÀ§ÀÔ´Ï´Ù.

ȯÀÚ À¯Çüº°·Î´Â 2024³â 2Çü ´ç´¢º´ÀÌ 1À§

ÃÖÁ¾»ç¿ëÀÚº°·Î º¸¸é 2024³â ÁÖ¿ä ÃÖÁ¾»ç¿ëÀÚ´Â ÀçÅÃÄ¡·á¿´½À´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2024³â ¸ÅÃâ 1À§¸¦ ±â·ÏÇß½À´Ï´Ù.

Ç÷´ç ÀÚ°¡ ÃøÁ¤ ±â±â ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼®

ÀÚ°¡Ç÷´çÃøÁ¤±â ¼¼°è ½ÃÀåÀº Á¦Ç° À¯Çü, ±â¼ú, °Ë»ç ºÎÀ§, ȯÀÚ À¯Çü, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

½ÃÀåÀº Á¦Ç° À¯Çü¿¡ µû¶ó ³× °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. ÀÚ°¡Ç÷´çÃøÁ¤±â(SMBG), °Ë»çÁö, ¶õ¼Â, Áö¼ÓÇ÷´çÃøÁ¤±âÀÔ´Ï´Ù. Ç÷´ç ÀÚ°¡ ÃøÁ¤(SMBG) ÃøÁ¤±â´Â µðÁöÅÐ ÃøÁ¤°ªÀ¸·Î Æí¸®ÇÑ ÃßÀûÀ» Á¦°øÇϸç, °Ë»ç ½ºÆ®¸³Àº Á¤È®ÇÏ°í ºü¸¥ °á°ú¸¦ º¸ÀåÇÕ´Ï´Ù. ·£½ËÀº äÇ÷¿¡ ÇʼöÀûÀ̸ç, ºÒÆíÇÔÀ» ÃÖ¼ÒÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. Áö¼ÓÀû Ç÷´ç ¸ð´ÏÅÍ´Â ½Ç½Ã°£ Ç÷´ç ÃßÀûÀ» °¡´ÉÇÏ°Ô ÇÏ¿© ´õ ³ªÀº ´ç´¢º´ °ü¸®¸¦ À§ÇÑ °ßÀÎÂ÷ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.

½ÃÀåÀº ±â¼ú¿¡ µû¶ó µÎ °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. Àü±âÈ­Çнİú ±¤µµ°è½ÄÀÔ´Ï´Ù. Àü±âÈ­ÇÐ ±â¼úÀº Á¤È®¼º, È޴뼺, ºñ¿ë È¿À²¼º¿¡¼­ ¿ìÀ§¸¦ Á¡Çϰí ÀÖÀ¸¸ç, SMBG Àåºñ¿¡ ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ±¤µµ ÃøÁ¤ ±â¼úÀº ³Î¸® º¸±ÞµÇÁö´Â ¾Ê¾ÒÁö¸¸, ½Ã°¢Àû ¼±¸íµµ¿Í ÇØ¼®ÀÇ ¿ëÀ̼ºÀ¸·Î ÀÎÇØ Ãʱ⠸𵨰ú ƯÁ¤ ÀÓ»ó ÀÀ¿ë¿¡ ÀÚÁÖ È°¿ëµÇ°í ÀÖ½À´Ï´Ù.

ÀÚ°¡ Ç÷´ç ÃøÁ¤ ±â±â ½ÃÀå - Áö¿ªÀû ÀλçÀÌÆ®

Ç÷´ç ÀÚ°¡ ÃøÁ¤ ±â±â ½ÃÀåÀº ÇコÄɾî ÀÎÇÁ¶ó, ´ç´¢º´ À¯º´·ü, ±â¼ú µµÀÔÀÇ ¿µÇâÀ» ¹Þ´Â Áö¿ª ¿ªÇÐÀ» º¸¿©ÁÝ´Ï´Ù. ºÏ¹Ì´Â ÷´ÜÈ­µÈ ÀÇ·á ½Ã½ºÅÛ°ú ³ôÀº ´ç´¢º´ À¯º´·ü·Î ÀÎÇØ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ±× ´ÙÀ½À¸·Î´Â À¯·´ÀÌ ÅºÅºÇÑ ÇコÄɾî Á¤Ã¥°ú ¸¹Àº ´ç´¢º´ Àα¸°¡ Ư¡ÀÔ´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ´ç´¢º´ À¯º´·ü Áõ°¡, ÀÇ·á ÀÎÇÁ¶ó °³¼±, ´ç´¢º´ °ü¸®¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡·Î ÀÎÇØ ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. Áß±¹, Àεµ, ÀϺ»°ú °°Àº ±¹°¡µéÀÌ ÀÌ·¯ÇÑ È®ÀåÀÇ ÃÖÀü¼±¿¡ ÀÖ½À´Ï´Ù. ¶óƾ¾Æ¸Þ¸®Ä«¿Í Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«´Â ÀÇ·á ¼­ºñ½º Á¢±Ù¼º Çâ»ó°ú °Ç°­ ÀνÄÀÇ Çâ»ó¿¡ ÈûÀÔ¾î ÀÌ·¯ÇÑ ±â¼úÀ» Á¡Â÷ µµÀÔÇϰí ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î ½ÃÀå ¼ºÀåÀº Áö¿ªº° ÀÇ·á ¿ì¼±¼øÀ§, °æÁ¦ »óȲ, ´ç´¢º´°ú °ü·ÃµÈ °Ç°­ ¹®Á¦ ÇØ°áÀÇ ½Ã±Þ¼º¿¡ µû¶ó °áÁ¤µÉ °ÍÀÔ´Ï´Ù.

ÀÚ°¡Ç÷´çÃøÁ¤±â ½ÃÀå - °æÀï ±¸µµ

ÀÚ°¡Ç÷´çÃøÁ¤(SMBG) ±â±â ½ÃÀåÀº ±âÁ¸ ÁøÀÔ±â¾÷°ú ½Å»ý Çõ½Å±â¾÷ÀÇ Ä¡¿­ÇÑ °æÀïÀÌ Æ¯Â¡ÀÔ´Ï´Ù. Abbott Laboratories, Dexcom, Roche Diagnostics, LifeScan, Ascensia Diabetes Care µî ÁÖ¿ä ±â¾÷Àº ÷´Ü ±â¼ú°ú ±¤¹üÀ§ÇÑ ÆÇ¸Å¸ÁÀ¸·Î ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. AbbottÀÇ FreeStyle Libre ½Ã¸®Áî´Â ¼¾¼­ ±â¼ú°ú ÇÕ¸®ÀûÀÎ °¡°ÝÀ¸·Î Æ÷µµ´ç ¸ð´ÏÅ͸µ¿¡ Çõ¸íÀ» ÀÏÀ¸Ä×À¸¸ç, DexcomÀÇ G6 ¹× G7 ½Ã½ºÅÛÀº Á¤È®¼º°ú »ç¿ëÀÚ Ä£È­ÀûÀÎ µðÀÚÀÎÀ¸·Î À¯¸íÇÕ´Ï´Ù. RocheÀÇ Accu-Chek ½Ã¸®Áî´Â ½Å·Ú¼º°ú µðÁöÅÐ Çコ Ç÷§Æû°úÀÇ ÅëÇÕÀ» Áß½ÃÇÏ¿© ¸¹Àº »ç¶÷µéÀÇ ½Å·Ú¸¦ ¹Þ°í ÀÖ½À´Ï´Ù. LifeScanÀÇ OneTouch Á¦Ç°Àº ´Ü¼øÇÔ°ú Á¤È®¼ºÀ» Ãß±¸ÇÑ ¼³°è·Î ´Ù¾çÇÑ »ç¿ëÀÚÃþÀ» ´ë»óÀ¸·Î ÇÕ´Ï´Ù. AscensiaÀÇ Contour ½Ã¸®Áî´Â ½Å·Ú¼º°ú »ç¿ëÀÚ Ä£È­ÀûÀÎ µðÀÚÀÎÀ¸·Î À¯¸íÇÕ´Ï´Ù. ¶ÇÇÑ ¿îµ¿¼±¼ö¿Í °Ç°­ ÁöÇâÀû ¼ÒºñÀÚ ¸ðµÎ¸¦ ´ë»óÀ¸·Î ÇÏ´Â Áö¼ÓÇü Ç÷´ç ÃøÁ¤±â Ultrahuman M1À» Ãâ½ÃÇÑ Ultrahuman°ú °°Àº ½Å±Ô ÁøÃâ±â¾÷µµ ½ÃÀå¿¡ ÁøÀÔÇϰí ÀÖ½À´Ï´Ù. Àü·«Àû Á¦ÈÞ, ±â¼ú ¹ßÀü, »ç¿ëÀÚ Á᫐ ¼³°è¿¡ ´ëÇÑ ÁýÁßÀº SMBG Àåºñ ½ÃÀåÀÇ °æÀï°ú Çõ½ÅÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÀÚ±â Ç÷´ç ÃøÁ¤ ±â±â ½ÃÀå °³¿ä

Á¦2Àå °³¿ä

Á¦3Àå ÀÚ±â Ç÷´ç ÃøÁ¤ ±â±âÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ÀÚ±â Ç÷´ç ÃøÁ¤ ±â±â »ê¾÷ Á¶»ç

Á¦5Àå ÀÚ±â Ç÷´ç ÃøÁ¤ ±â±â ½ÃÀå : ³ô¾ÆÁö´Â ÁöÁ¤ÇÐÀû ±äÀåÀÇ ¿µÇâ

Á¦6Àå ÀÚ±â Ç÷´ç ÃøÁ¤ ±â±â ½ÃÀå ±¸µµ

Á¦7Àå ÀÚ±â Ç÷´ç ÃøÁ¤ ±â±â ½ÃÀå - Á¦Ç° À¯Çüº°

Á¦8Àå ÀÚ±â Ç÷´ç ÃøÁ¤ ±â±â ½ÃÀå - ±â¼úº°

Á¦9Àå ÀÚ±â Ç÷´ç ÃøÁ¤ ±â±â ½ÃÀå - °Ë»ç ºÎÀ§º°

Á¦10Àå ÀÚ±â Ç÷´ç ÃøÁ¤ ±â±â ½ÃÀå - ȯÀÚ À¯Çüº°

Á¦11Àå ÀÚ±â Ç÷´ç ÃøÁ¤ ±â±â ½ÃÀå - ÃÖÁ¾»ç¿ëÀÚº°

Á¦12Àå ÀÚ±â Ç÷´ç ÃøÁ¤ ±â±â ½ÃÀå - Áö¿ª

Á¦13Àå ÁÖ¿ä º¥´õ ºÐ¼® - ÀÚ±â Ç÷´ç ÃøÁ¤ ±â±â »ê¾÷

Á¦14Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Self-monitoring Blood Glucose Devices Market size was valued at US$ 19,752.01 Million in 2024, expanding at a CAGR of 11.53% from 2025 to 2032.

The Self-monitoring Blood Glucose Devices Market involves portable devices that enable individuals to measure their blood glucose levels independently, playing a crucial role in diabetes management worldwide. Rising diabetes prevalence and increasing awareness about self-care practices are expanding the demand for these devices. According to the World Health Organization, over 422 million people globally are affected by diabetes, emphasizing the importance of regular glucose monitoring. However, challenges such as high costs of advanced devices and limited accessibility in low-income regions can hinder widespread adoption. Opportunities lie in technological advancements like continuous glucose monitoring integration, non-invasive sensors, and smartphone connectivity, which improve user experience and data accuracy. Additionally, growing government initiatives promoting diabetes screening and management are enhancing market penetration, especially in developing countries where early diagnosis and consistent monitoring can significantly improve patient outcomes.

Self-monitoring Blood Glucose Devices Market- Market Dynamics

Rising diabetes prevalence and tech innovations to boost self-monitoring glucose device demand

Rising diabetes prevalence combined with rapid technological innovations is driving greater adoption of self-monitoring blood glucose devices globally. The International Diabetes Federation reports that approximately 1 in 10 adults worldwide lives with diabetes, underscoring the urgent need for effective self-care tools. Advances such as non-invasive sensors and mobile app integration are making glucose monitoring more convenient and accurate. The U.S. Centers for Disease Control and Prevention (CDC) emphasizes that regular blood glucose monitoring can significantly reduce complications and improve quality of life for diabetic patients. Furthermore, government health programs in countries like India and Brazil are increasing access to these devices through subsidies and awareness campaigns, helping millions manage their condition more effectively and reducing the burden on healthcare systems.

Self-monitoring Blood Glucose Devices Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.53% over the forecast period (2025-2032)

Based on product type segmentation, Self-Monitoring Blood Glucose (SMBG) Meters were predicted to show maximum market share in the year 2024

Based on Technology segmentation, Electrochemical technology was the leading Technology in 2024

Based on Testing Site segmentation, Fingertip was the leading Testing Site in 2024

Based on Patient Type segmentation, Type 2 Diabetes was the leading Patient Type in 2024

Based on end user segmentation, Home Care was the leading end user in 2024

On the basis of region, North America was the leading revenue generator in 2024

Self-monitoring Blood Glucose Devices Market- Segmentation Analysis:

The Global Self-monitoring Blood Glucose Devices Market is segmented on the basis of Product Type, Technology, Testing Site, Patient Type, End User, and Region.

The market is divided into four categories based on product type: Self-Monitoring Blood Glucose (SMBG) Meters, Test Strips, Lancets, and Continuous Glucose Monitors. Self-Monitoring Blood Glucose (SMBG) Meters offer convenient tracking with digital readings, while Test Strips ensure accuracy and quick results. Lancets are vital for blood sampling, offering minimal discomfort. Continuous Glucose Monitors enable real-time glucose tracking, gaining traction for better diabetes management.

The market is divided into two categories based on Technology: Electrochemical and Photometric. Electrochemical technology dominates due to its precision, portability, and cost-effectiveness, commonly used in SMBG devices. Photometric technology, though less prevalent, is valued for its visual clarity and ease of interpretation, often utilized in earlier models and specific clinical applications.

Self-monitoring Blood Glucose Devices Market- Geographical Insights

The Self-Monitoring Blood Glucose Devices Market exhibits regional dynamics influenced by healthcare infrastructure, diabetes prevalence, and technological adoption. North America leads with advanced healthcare systems and high diabetes rates, driving demand for glucose monitoring devices. Europe follows, characterized by robust healthcare policies and a significant diabetic population. The Asia-Pacific region is experiencing rapid growth due to increasing diabetes prevalence, improving healthcare infrastructure, and rising awareness about diabetes management. Countries like China, India, and Japan are at the forefront of this expansion. Latin America and the Middle East & and Africa are gradually adopting these technologies, supported by improving healthcare access and rising health awareness. Overall, the market's growth is shaped by regional healthcare priorities, economic conditions, and the urgency of addressing diabetes-related health challenges.

Self-monitoring Blood Glucose Devices Market- Competitive Landscape:

The Self-Monitoring Blood Glucose (SMBG) Devices Market is characterized by intense competition among established players and emerging innovators. Leading companies such as Abbott Laboratories, Dexcom, Roche Diagnostics, LifeScan, and Ascensia Diabetes Care dominate the market with their advanced technologies and extensive distribution networks. Abbott's FreeStyle Libre series has revolutionized glucose monitoring with its sensor technology and affordability, while Dexcom's G6 and G7 systems are renowned for their accuracy and user-friendly design. Roche's Accu-Chek line continues to be a trusted choice for many, emphasizing reliability and integration with digital health platforms. LifeScan's OneTouch products are designed for simplicity and accuracy, catering to a broad user base. Ascensia's Contour series is known for its reliability and user-friendly design. The market is also witnessing the entry of new players like Ultrahuman, which launched its continuous glucose monitor, Ultrahuman M1, targeting both athletes and health-conscious consumers. Strategic collaborations, technological advancements, and a focus on user-centric designs are key factors driving competition and innovation in the SMBG devices market.

Recent Developments:

In July 2024, Roche received CE Mark for its Accu-Chek SmartGuide(R) continuous glucose monitoring (CGM) device. Designed for adults with type 1 and type 2 diabetes, it offers real-time glucose readings and AI-powered predictive alerts for improved self-management.

In May 2024, Intuity Medical and embecta have announced a commercial collaboration to expand access to Intuity's POGO Automatic(R) Blood Glucose Monitoring System, aiming to enhance self-monitoring options and diabetes care for patients across the United States.

In April 2023, Astellas and Roche Diabetes Care Japan partnered to develop and commercialize an integrated diabetes self-management solution featuring Roche's blood glucose monitoring devices and the BlueStar digital health platform, aiming to improve diabetes care in Japan.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY TESTING SITE- MARKET ANALYSIS, 2019 - 2032

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PATIENT TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Self-monitoring Blood Glucose Devices Market Overview

2. Executive Summary

3. Self-monitoring Blood Glucose Devices Key Market Trends

4. Self-monitoring Blood Glucose Devices Industry Study

5. Self-monitoring Blood Glucose Devices Market: Impact of Escalating Geopolitical Tensions

6. Self-monitoring Blood Glucose Devices Market Landscape

7. Self-monitoring Blood Glucose Devices Market - By Product Type

8. Self-monitoring Blood Glucose Devices Market - By Technology

9. Self-monitoring Blood Glucose Devices Market - By Testing Site

10. Self-monitoring Blood Glucose Devices Market - By Patient Type

11. Self-monitoring Blood Glucose Devices Market - By End User

12. Self-monitoring Blood Glucose Devices Market- By Geography

13. Key Vendor Analysis- Self-monitoring Blood Glucose Devices Industry

14. 360 Degree Analyst View

15. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â